As clearly demonstrated by these fictional portrayals, OCD severely impacts and disrupts the everyday functioning of adults living with the condition. Will ketamine, the new hope for the treatment of obsessive compulsive disorder (OCD) and other severe mental illnesses, live up to it's promise? For the almost 500,000 Australians who suffer from Obsessive-Compulsive Disorder, hope is on the horizon as NICM Health Research Institute researchers trial a new treatment which has shown promising results in previous studies. With OCD, patients are exposed to scenarios that trigger their compulsions. Stanford ENT surgeon discusses how viruses cause a loss of sense of smell, and what you should do about it in the era of the coronavirus pandemic. Promising new nutrient treatment gives hope to OCD sufferers Embargoed until: Publicly released: 2018-11-26 00:01 For the almost 500,000 Australians who suffer from Obsessive-Compulsive Disorder, hope is on the horizon as NICM Health Research Institute researchers trial a new treatment which has shown promising results in previous studies. High-frequency deep transcranial magnetic stimulation (dTMS) may offer new hope for patients with treatment-resistant obsessive-compulsive disorder (OCD), new … Last month, my colleague Tracie Write Beginning more than a decade ago with a study funded by the National Institutes of Health that showed ketamine infusions infusions inducing dramatic improvements in treatment-resistant depression, ketamine research has burst into the field of psychiatry, spurring studies like Rodriquez's that have shown success in treating OCD, bipolar disorder and post-tramuatic stress disorder.Rodriguez told me the current go-to treatments for OCD -- A lesser known truth about OCD is … He hopes that the trial will lead to an effective treatment to reduce the suffering of patients for whom no effective treatment exists.“OCD is a debilitating mental health disorder and the need remains for additional therapies to help peoplereduce their obsessions and compulsions,” Professor Sarris said.“Our clinical trial is designed to look at people who are still unwell with OCD and who need to take medication,but the currently available medicines only provide a certain amount of relief.“NAC targets a variety of neurochemical pathways which are indicated in a range of mental health disorders.“If this trial proves successful, we may see NAC used as a standard additional treatment for people with OCD in the next few years.”Professor Sarris urges anyone experiencing OCD symptoms to contact their GP, medical professional, or Lifeline on 13 11 14.Recruitment for the NAC trial is now underway in NSW at Western Sydney University's Westmead campus, in VIC at the University of Melbourne based in Richmond, and QLD at The University of Queensland, Herston.For more details about how to participate visit www.ocd-research.comFor more information about NICM visit www.nicm.edu.auMedia contact details for this story are only visible to registered journalists.
Copyright © Australian Science Media Centre Inc. This 1:2:1 podcast features a conversation with psychiatrist Carolyn Rodriguez on the use of ketamine to treat OCD. OCD is a debilitating mental health disorder and under current treatment options around 40 per cent of patients receive only minimal relief from symptoms. ... And so when you have a patient and you're treating them for OCD, about a third of patients, maybe a little bit more, continue to have debilitating symptoms, symptoms that interfere with their daily life that interfere with their quality of life their ability to do things and to engage with others and … Thank you! As schools begin to reopen, Stanford pediatrician Jason Wang, MD, PhD, discusses best COVID-19 safety practices, and why kids should be in the classroom.